Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 371-376

  Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine; Adenosine kinase; Arthritis; Inflammation; Sepsis

Indexed keywords

4 AMINO 3 BROMOPYRAZOLO[3,4 D]PYRIMIDINE 1 (5 AMINO 5 DEOXYRIBOSIDE); ADENOSINE; ADENOSINE KINASE INHIBITOR; ANTIINFLAMMATORY AGENT; INDOMETACIN; PIROXICAM; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; RAT;

EID: 0030441284     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<371::AID-DDR18>3.0.CO;2-4     Document Type: Conference Paper

References (31)

1. Adkins WK, Barnard JW, May S, Seibert AB, Haynes J, Taylor AE (1992): Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J Appl Physiol 72:492-497.
2. 2 receptor mechanism. J Appl Physiol 74:982-988.
3. Asako H, Wolf RE, Granger DN (1993): Leukocyte adherence in rat mesenteric venules: Effects of adenosine and methotrexate. Gastroenterology 104:31-37.
4. Belardinelli L, Linden J, Berne RM (1989): The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73-97.
5. Boyle DL, Sajjadi FG, Firestein GS (1996): Adenosine receptor stimulation inhibits synoviocyte collagenase gene expression. Arthritis Rheum 39:923-930.
6. Brackett LE, Daly JW (1994): Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814.
7. Casnocha SA, Eskin SG, Hall ER, McIntire LV (1989): Permeability of human endothelial monolayers: Effect of vasoactive agonists and cAME. J Appl Physiol 67:1997-2005.
8. Clohisy JC, Connolly TJ, Bergman KD, Quinn CO, Partridge NC (1994): Prostanoid-induced expression of matrix metalloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells. Endocrinology 135:1447-1454.
9. Corcoran ML, Stetler-Stevenson WG, DeWitt DL, Wahl LM (1994): Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys 310: 481-488.
10. Cottam HB, Wasson DB, Shih HC, Raychaudhuri A, Di Pasquale G, Carson DA (1993): New adenosine kinase inhibitors with oral antiinflammatory activity: Synthesis and biological evaluation. J Med Chem 36:3424-3430.
11. Cronstein BN, Daguma LD, Nichols AJ, Hutchison, Williams M (1990): The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85:1150-1157.
12. Cronstein BN, Eberle ME, Gruber HE, Levin RI (1991): Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88:2441-2445.
13. Cronstein BN, Naime D, Ostad E (1993): The anti-inflammatory mechanism of low-dose methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 92:2675-2682.
14. Cronstein B, Naime D, Firestein GS (1995): The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 38:1040-1045.
15. Firestein GS, Boyle D, Bullough DA, Sajjadi FG, Montag A, Samhol B, Mullane KM (1994): Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol, 152:5853-5859.
16. Firestein GS, Bullough DA, Erion MD, Jimenez R, Ramirez-Weinhouse M, Barankiewicz. J, Smith CW, Gruber HE, Mullane KM (1995): Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol 154:326-334.
17. Grisham MB, Hernandez LA, Granger DN (1989): Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol 257:H1334-H1339.
18. Haselton FR, Alexander JS, Mueller SN (1993): Adenosine decreases permeability of in vitro endothelial monolayers. J Appl Physiol 74:1581-1590.
19. McCarthy GM, Cheung HS (1994): The role of cyclic-3′,5′-adenosine monophosphate in prostaglandin-mediated inhibition of basic calcium phosphate crystal-induced mitogenesis and collagenase induction in cultured human fibroblasts. Biochim Biophys Acta 1226:97-104.
20. Olafsson B, Forman MB, Puett DW, Pou A, Cates CU, Friesinger GC, Virmani R (1987): Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135-1140.
21. Paty PSK, Sherman PF, Shepard JM, Malik AB, Kaplan JE (1992): Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am J Physiol 262:H771-H777.
22. Perry M, Taylor AM (1988): Phorbol myristate acetate-induced injury of isolated perfused rat lungs: Neutrophil dependence. J Appl Physiol 65:2164-2169.
23. Rivkees SA, Reppert SM (1992): RFL9 encodes an A2b-adenosine receptor. Mol Endocrinol 6:1598-1604.
24. Rosengren S, Bong GW, Firestein GS (1995): Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Imnmnol 154:5444-5451.
25. Sajjadi FC, Takabayashi K, Foster A, Domingo R, Firestein GS (1996): Inhibition of TNF-alpha gene expression by adenosine: The role of A3 adenosine receptors. J Immunol 156:3435-3442.
26. Salvatori R, Guidon Jr. PT, Rapuano BE, Bockman RS (1992): Prostaglandin E1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts. Endocrinology 131:21-28.
27. Schrier DJ, Lesch ME, Wright CD, Gilbertsen RB (1990): The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J Immunol 145:1874-1879.
28. Stelzner TJ, Weil JV, O'Brien RF (1989): Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol 139:157-166.
29. Sugio K, Daly JW (1983): Effect of forskolin on alterations of vascular permeability induced with bradykinin. prostaglandin E1, adenosine, histamine and carrageenan in rats. Life Sci 33:65-73.
30. Takahashi S, Ito A, Nagino M, Mori Y, Xie B, Nagase H (1991): Cyclic adenosine 3′,5′-monophosphate suppresses interleukin 1-induced synthesis of matrix metalloproteinases but not of tissue inhibitor of metalloproteinases in human uterine cervical fibroblasts. J Biol Chem 266:19894-19899.
31. Watanabe H, Kuhne W, Schwartz P, Piper HM (1992): A2-adenosine receptor stimulation increases macromolecule permeability of coronary endothelial cells. Am J Physiol 262:H1174-H1181.